Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults : a multi-country analysis

Source
BMC medicine - ISSN 1741-7015-23:1 (2025) p. 1-17
Author(s)

Management cost of acute respiratory infections in older adults in China : a systematic review and meta-analysis

Source
Journal of Global Health - ISSN 2047-2978-14 (2024) p. 1-10
Author(s)
    Xiaoyu Xu, Tiantian Zhang, Yumeng Miao, Xiao Li, You Li

Pricey or priceless : cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants

Source
The Lancet regional health. Americas - ISSN 2667-193X-29 (2024) p. 1-2

COVID-19-related health utility values and changes in COVID-19 patients and the general population : a scoping review

Source
Quality of life research - ISSN 0962-9343-33:6 (2024) p. 1443-1454
Author(s)

Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022

Source
Vaccine - ISSN 0264-410X-41:48 (2023) p. 7047-7059
Author(s)
    Meagan C. Fitzpatrick, Rachel S. Laufer, Ranju Baral, Amanda J. Driscoll, Daniel R. Feikin, Jessica A. Fleming, Mark Jit, Sonnie Kim, Mihaly Koltai, You Li, Xiao Li, Harish Nair, Kathleen M. Neuzil, Clint Pecenka, Erin Sparrow, Padmini Srikantiah, Justin R. Ortiz